Key Takeaways
- Spex Capital launches a €100 million Venture HealthTech Fund, with an initial €30 million commitment.
- The fund aims to support early-stage HealthTech startups globally, making investments of up to €5 million.
- Partnerships with EIT Digital and Penn Medicine will enhance access to essential validation networks for scaling health technologies.
Spex Capital Launches New HealthTech Fund
London-based Spex Capital has announced the establishment of its €100 million Venture HealthTech Fund, making an initial commitment of €30 million. This fund is targeted at early-stage HealthTech startups, focusing on funding from Seed to Series A/B, with potential investments reaching up to €5 million.
Claudio D’Angelo, the Founder and CEO, emphasized the significant challenges healthcare faces globally due to aging populations increasing patient demand and systemic cost pressures. He noted that Spex Capital’s unique advantage lies in its powerful distribution network, which offers crucial validation for companies seeking to scale.
Investment activity in the European healthtech sector remains robust. Other funds, such as Meridian Health Ventures and Capricorn Partners, have recently launched similar initiatives, signaling a growing investor interest in early-stage digital health and medical innovations. Spex Capital’s fund stands out as one of the largest upcoming European initiatives, underscoring the rising confidence in the HealthTech sector.
With partnerships including EIT Digital and Penn Medicine, Spex Capital aims to leverage extensive validation networks, which are often a limiting factor in scaling health technologies. Recent reports reveal that European healthtech investment exceeded €4 billion in early 2025, reinforcing the notion that investors are keen to explore opportunities in digital health and medical innovation.
D’Angelo remarked that while many startups exist, the validation provided through their network is a critical differentiator. He believes that Digital HealthTech plays a pivotal role in addressing healthcare challenges and, with their new fund, partnerships, and advisory network, they are uniquely positioned to back transformative founders worldwide.
In conjunction with this announcement, Lord Markham, former UK Health Minister, has been appointed Chair of the Board. Markham brings significant experience from both public and private sectors, previously co-founding HealthTech business Cignpost, which rapidly scaled from €0 to €350 million turnover within a year. He expressed his enthusiasm about joining Spex Capital during such a crucial phase for HealthTech, stating that this scale-up fund will empower innovative startups and improve global healthcare delivery.
Spex Capital was founded in 2021 with the objective of commercializing and scaling digital health and medical technology solutions across major healthcare systems worldwide.
The content above is a summary. For more details, see the source article.
